Bank Of New York Mellon Corp Coh Bar, Inc. Transaction History

Bank Of New York Mellon Corp

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$1.09 - $1.49 $67,123 - $91,755	-61,581 Reduced 81.61%	13,875 $19,000
Q1 2021 May 13, 2021	BUY	$1.26 - $2.02 $22,759 - $36,487	18,063 Added 31.47%	75,456 $102,000
Q4 2020 Feb 09, 2021	SELL	$0.9 - $1.54 $2,670 - $4,569	-2,967 Reduced 4.92%	57,393 $76,000
Q2 2020 Aug 12, 2020	BUY	$1.08 - $4.0 $22,721 - $84,152	21,038 Added 53.5%	60,360 $93,000
Q3 2019 Nov 07, 2019	BUY	$1.3 - $1.76 $31,332 - $42,419	24,102 Added 158.36%	39,322 $51,000
Q2 2019 Aug 12, 2019	SELL	$1.63 - $3.3 $98,641 - $199,702	-60,516 Reduced 79.9%	15,220 $26,000
Q1 2019 May 14, 2019	SELL	$2.95 - $4.16 $2,566 - $3,619	-870 Reduced 1.14%	75,736 $247,000
Q4 2018 Feb 11, 2019	BUY	$2.97 - $4.52 $47,490 - $72,274	15,990 Added 26.38%	76,606 $238,000
Q3 2018 Nov 09, 2018	BUY	$4.13 - $6.84 $123 - $205	30 Added 0.05%	60,616 $0
Q2 2018 Aug 06, 2018	BUY	$4.44 - $10.4 $269,001 - $630,094	60,586 New	60,586 $397,000

1.14K

Ticker CWBR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,906,940
Market Cap $1.19M
Description
CohBar, Inc., a clinical stage biotechnology company, focuses in the research and development of mitochondria based therapeutics (MBTs) for the treatment of chronic and age-related diseases. The company develops MBTs to treat non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, idiopathic pulmonary fibrosis, type 2 diabetes, acute...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.